When genetic test results for your patients come back with variants of unknown significance, how do you truly determine hereditary cancer risk and provide medical management recommendations? What if there’s a solution for DNA testing’s limited interpretations?

In this webinar, we share our experience pairing DNA and RNA sequencing to yield more accurate results. We’ll include an in-depth look at several cases to illustrate the potential benefit to individuals and their families.

Questions We'll Answer:

• How is RNA evidence interpreted and applied toward variant classification?
• How does improved test accuracy translate to clinical significance for high-risk cancer patients? (Presented with case examples!)

Presenters
Carrie Horton, MS, CGC
Sr. Clinical Researcher Specialist 

Terra Brannan, PhD
Variant Assessment Scientist

Jessica Grzybowski, MS, CGC
Lead Genetic Counselor